Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,614 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Soluble Vascular Biomarkers in Rheumatoid Arthritis and Ankylosing Spondylitis: Effects of 1-year Antitumor Necrosis Factor-α Therapy.
Pusztai A, Hamar A, Horváth Á, Gulyás K, Végh E, Bodnár N, Kerekes G, Czókolyová M, Szamosi S, Bodoki L, Hodosi K, Domján A, Nagy G, Szöllősi I, Lopez LR, Matsuura E, Prohászka Z, Szántó S, Nagy Z, Shoenfeld Y, Szekanecz Z, Szűcs G. Pusztai A, et al. Among authors: horvath a. J Rheumatol. 2021 Jun;48(6):821-828. doi: 10.3899/jrheum.200916. Epub 2020 Dec 15. J Rheumatol. 2021. PMID: 33323530
Changes of Metabolic Biomarker Levels upon One-Year Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis: Associations with Vascular Pathophysiology.
Czókolyová M, Pusztai A, Végh E, Horváth Á, Szentpéteri A, Hamar A, Szamosi S, Hodosi K, Domján A, Szántó S, Kerekes G, Seres I, Harangi M, Paragh G, Szekanecz É, Szekanecz Z, Szűcs G. Czókolyová M, et al. Among authors: horvath a. Biomolecules. 2021 Oct 18;11(10):1535. doi: 10.3390/biom11101535. Biomolecules. 2021. PMID: 34680168 Free PMC article.
Angiotensin Converting Enzyme Activity in Anti-TNF-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients.
Soós B, Fagyas M, Horváth Á, Végh E, Pusztai A, Czókolyová M, Csongrádi A, Hamar A, Pethő Z, Bodnár N, Kerekes G, Hodosi K, Szekanecz É, Szamosi S, Szántó S, Szűcs G, Papp Z, Szekanecz Z. Soós B, et al. Among authors: horvath a. Front Med (Lausanne). 2022 Jan 27;8:785744. doi: 10.3389/fmed.2021.785744. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35155468 Free PMC article.
Real-life experience with switching TNF-α inhibitors in ankylosing spondylitis.
Gulyas K, Bodnar N, Nagy Z, Szamosi S, Horvath A, Vancsa A, Vegh E, Szabo Z, Szucs G, Szekanecz Z, Szanto S. Gulyas K, et al. Among authors: horvath a. Eur J Health Econ. 2014 May;15 Suppl 1:S93-100. doi: 10.1007/s10198-014-0598-0. Epub 2014 May 16. Eur J Health Econ. 2014. PMID: 24832840
Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis.
Gulyás K, Horváth Á, Végh E, Pusztai A, Szentpétery Á, Pethö Z, Váncsa A, Bodnár N, Csomor P, Hamar A, Bodoki L, Bhattoa HP, Juhász B, Nagy Z, Hodosi K, Karosi T, FitzGerald O, Szücs G, Szekanecz Z, Szamosi S, Szántó S. Gulyás K, et al. Among authors: horvath a. Clin Rheumatol. 2020 Jan;39(1):167-175. doi: 10.1007/s10067-019-04771-3. Epub 2019 Sep 14. Clin Rheumatol. 2020. PMID: 31522318
Peripheral quantitative computed tomography in the assessment of bone mineral density in anti-TNF-treated rheumatoid arthritis and ankylosing spondylitis patients.
Juhász B, Gulyás K, Horváth Á, Végh E, Pusztai A, Szentpétery Á, Pethő Z, Bodnár N, Hamar A, Bodoki L, Bhattoa HP, Szekanecz É, Hodosi K, Domján A, Szamosi S, Horváth C, Szántó S, Szűcs G, Raterman HG, Lems WF, FitzGerald O, Szekanecz Z. Juhász B, et al. Among authors: horvath c, horvath a. BMC Musculoskelet Disord. 2021 Sep 23;22(1):817. doi: 10.1186/s12891-021-04708-5. BMC Musculoskelet Disord. 2021. PMID: 34556105 Free PMC article.
Associations of vascular and bone status in arthritis patients.
Pusztai A, Hamar A, Czókolyová M, Gulyás K, Horváth Á, Végh E, Pethő Z, Szamosi S, Balogh E, Bodnár N, Bodoki L, Szentpétery Á, Bhattoa HP, Kerekes G, Juhász B, Szekanecz É, Hodosi K, Domján A, Szántó S, Raterman HG, Lems WF, Szekanecz Z, Szűcs G. Pusztai A, et al. Among authors: horvath a. Sci Rep. 2021 Sep 30;11(1):19504. doi: 10.1038/s41598-021-99071-9. Sci Rep. 2021. PMID: 34593938 Free PMC article.
Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis.
Hamar A, Szekanecz Z, Pusztai A, Czókolyová M, Végh E, Pethő Z, Bodnár N, Gulyás K, Horváth Á, Soós B, Bodoki L, Bhattoa HP, Nagy G, Tajti G, Panyi G, Szekanecz É, Domján A, Hodosi K, Szántó S, Szűcs G, Szamosi S. Hamar A, et al. Among authors: horvath a. Osteoporos Int. 2021 Aug;32(8):1621-1629. doi: 10.1007/s00198-021-05871-0. Epub 2021 Feb 9. Osteoporos Int. 2021. PMID: 33559714 Free PMC article.
Effects of targeted therapies on the bone in arthritides.
Szentpétery Á, Horváth Á, Gulyás K, Pethö Z, Bhattoa HP, Szántó S, Szücs G, FitzGerald O, Schett G, Szekanecz Z. Szentpétery Á, et al. Among authors: horvath a. Autoimmun Rev. 2017 Mar;16(3):313-320. doi: 10.1016/j.autrev.2017.01.014. Epub 2017 Jan 31. Autoimmun Rev. 2017. PMID: 28159704 Review.
1,614 results